SEC 13F Intelligence

Sofinnova Investments, Inc. / RAPP

Sofinnova Investments, Inc.’s Rapport Therapeutics Inc Position

Does Sofinnova Investments, Inc. own Rapport Therapeutics Inc (RAPP)? Yes — 1.90M shares worth $60M (+2.26% of its 13F portfolio) as of Q1 2026.

Position Value
$60M
Q1 2026
Shares
1.90M
% of Portfolio
+2.26%
Quarters Held
7
currently held

Position History RAPP

Reported value by quarter
Q3 ’24: $41MQ3 ’24Q4 ’24: $35MQ4 ’24Q1 ’25: $20MQ1 ’25Q2 ’25: $23MQ2 ’25Q3 ’25: $58MQ3 ’25Q4 ’25: $58MQ4 ’25Q1 ’26: $60MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.90M$60M+2.26%
Q4 20251.90M$58M+2.49%
Q3 20251.95M$58M+3.16%
Q2 20252.00M$23M+1.39%
Q1 20252.00M$20M+1.31%
Q4 20242.00M$35M+2.58%
Q3 20242.00M$41M+3.24%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sofinnova Investments, Inc.’s full portfolio or all institutional holders of RAPP.